title: Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
abstract: The aim of the study was to investigate the physical stability of the semi-solid dispersions into the hard gelatine capsules prepared with Gelucire 44/14, Labrasol and different additives such as microcrystalline cellulose (MCC), mannitol and lactose (alpha-monohydrate) used for enhancing the stability of the formulations. The master dispersion prepared with only Gelucire 44/14 (20% w/w) and Labrasol (80% w/w) was stored in a refrigerator (5 +/- 3 degrees C), while the modified dispersions with the additives (2% w/w) were kept in a climatic chamber (25 +/- 2 degrees C / 60 +/- 5% RH) for 12 months. Dissolution tests of the semi-solid dispersions were performed in media with different pH's immediatly after preparation and after 3, 6 and 12 months of storage. FTIR and DSC studies were also carried out at the same time points. The ideal storage condition for the master dispersion was found to be at 5 degrees C. The addition of MCC, mannitol and lactose (alpha-monohydrate) to the original dispersion afforded a solidification effect on the formulation at room temperature and showed the same dissolution behavior (not less than 85% of piroxicam within 30 min in pH 1.2, 4.5 and 6.8; and water) with the master. The dispersion including lactose was stable at 25 degrees C for 12 months. However, the ideal period of storage for the modified dispersions including MCC and mannitol was 6 months at 25 degrees C. FTIR and DSC results both confirmed the amorphous state of piroxicam in all semi-solid dispersions under storage conditions for 12 months.
authors.affiliation: Department of Pharmaceutical Technology, School of Pharmacy, Ankara University, 06100-Tandoğan, Ankara, Turkey. akaratas@pharmacy.ankara.edu.tr
authors.forename: Ayşegül
authors.initials: A
authors.lastname: Karataş
authors.forename: Serife
authors.initials: S
authors.lastname: Bekmezci
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000737:chemistry*; D002138:Calibration; D002152:Calorimetry, Differential Scanning; D002214:Capsules; D002626:Chemistry, Pharmaceutical; D004339:Drug Compounding; D004355:Drug Stability; D004356:Drug Storage; D005079:Excipients; D005780:Gelatin; D006863:Hydrogen-Ion Concentration; D010894:Piroxicam / Q000008:administration & dosage / Q000737:chemistry*; D011092:Polyethylene Glycols; D015203:Reproducibility of Results; D017550:Spectroscopy, Fourier Transform Infrared; D013696:Temperature
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002214:Capsules; D005079:Excipients; C104509:gelucire 44-14; D010894:Piroxicam; D011092:Polyethylene Glycols; D005780:Gelatin